Review



nucli-sens easy mag automated platform  (bioMerieux gmbh)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    bioMerieux gmbh nucli-sens easy mag automated platform
    Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
    Nucli Sens Easy Mag Automated Platform, supplied by bioMerieux gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nucli-sens+easy+mag+automated+platform/nucli+sens+easy+mag+automated+platform/pmc08123338-10-12-17
    Average 90 stars, based on 1 article reviews
    nucli-sens easy mag automated platform - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Role of Circulating Tumor DNA in Hematological Malignancy"

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy

    Journal: Cancers

    doi: 10.3390/cancers13092078

    Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
    Figure Legend Snippet: Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).

    Techniques Used: Isolation, Clinical Proteomics, Mutagenesis, Electrophoresis, Virus, Methylation, Clone Assay, Sequencing, Biomarker Discovery, Diagnostic Assay, Nucleic Acid Electrophoresis, Transplantation Assay

    Related Articles

    Clinical Proteomics:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Next-Generation Sequencing:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Sequencing:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Biomarker Discovery:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Isolation:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Mutagenesis:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Electrophoresis:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Virus:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Methylation:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Clone Assay:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Diagnostic Assay:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Nucleic Acid Electrophoresis:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Transplantation Assay:

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy
    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.



    Similar Products

    nucli-sens easy mag automated platform  (bioMerieux gmbh)
    90
    bioMerieux gmbh nucli-sens easy mag automated platform
    Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
    Nucli Sens Easy Mag Automated Platform, supplied by bioMerieux gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nucli-sens+easy+mag+automated+platform/nucli+sens+easy+mag+automated+platform/pmc08123338-10-12-17
    Average 90 stars, based on 1 article reviews
    nucli-sens easy mag automated platform - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).

    Journal: Cancers

    Article Title: Role of Circulating Tumor DNA in Hematological Malignancy

    doi: 10.3390/cancers13092078

    Figure Lengend Snippet: Description of the studies examining cell-free DNA (cfDNA) for acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).

    Article Snippet: Albitar, F. 2016 [ ] , MDS , 16 , Plasma , Nucli-SENS Easy MAG Automated Platform (BioMerieux, Marcy- l’E’ toile, France) , NGS (target sequence) , 14 target genes ( ASXL1 , ETV6 , EZH2 , IDH1 , IDH2 , NRAS , CBL , RUNX1 , SF3B1 , SRSF2 , TET2 , TP53 , U2AF1 , ZRSR2 ) , SNV/Indel , Confirmed the presence of a neoplastic abnormal MDS clone using cfDNA NGS , Further validation in advanced MDS patients.

    Techniques: Isolation, Clinical Proteomics, Mutagenesis, Electrophoresis, Virus, Methylation, Clone Assay, Sequencing, Biomarker Discovery, Diagnostic Assay, Nucleic Acid Electrophoresis, Transplantation Assay